Image pharmaphorum Editor Market Access Is it time to rethink electronic prescribing in the US? It is a fact of life that most – if not all – patients will require some form of prescription medication during their lifetime. Market Access Closing the digital expectation gap in pharma Jan Deman is Takeda’s head of digital customer experience for Europe and Canada. But he’d prefer not to refer to what he does as “innovation”. Market Access Combination pricing: access to the future of oncology treatm... Combination therapies are fast becoming the cornerstone of cancer treatment: not just in the UK, but across the world. Market Access Rethinking value: why diverse viewpoints matter Value is a tricky concept to capture accurately. Load more results
Market Access Is it time to rethink electronic prescribing in the US? It is a fact of life that most – if not all – patients will require some form of prescription medication during their lifetime.
Market Access Closing the digital expectation gap in pharma Jan Deman is Takeda’s head of digital customer experience for Europe and Canada. But he’d prefer not to refer to what he does as “innovation”.
Market Access Combination pricing: access to the future of oncology treatm... Combination therapies are fast becoming the cornerstone of cancer treatment: not just in the UK, but across the world.
Market Access Rethinking value: why diverse viewpoints matter Value is a tricky concept to capture accurately.
News UK offers meningitis jab to young people after outbreak The UK government has responded to calls to broaden vaccinations for meningitis B, offering the jab to "thousands" of young people this summer.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
